title: Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII: considerations on the differentiation between the 2 circulating anticoagulants.
authors.affiliation: Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Internal Medicine and Dermatology, University and Foundation IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy. armando.tripodi@unimi.it
authors.forename: Armando
authors.initials: A
authors.lastname: Tripodi
authors.forename: Maria Elisa
authors.initials: ME
authors.lastname: Mancuso
authors.forename: Veena
authors.initials: V
authors.lastname: Chantarangkul
authors.forename: Marigrazia
authors.initials: M
authors.lastname: Clerici
authors.forename: Rossella
authors.initials: R
authors.lastname: Bader
authors.forename: Pier Luigi
authors.initials: PL
authors.lastname: Meroni
authors.forename: Elena
authors.initials: E
authors.lastname: Santagostino
authors.forename: Pier Mannuccio
authors.initials: PM
authors.lastname: Mannucci
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D005169:Factor VIII / Q000032:analysis / Q000037:antagonists & inhibitors*; D005500:Follow-Up Studies; D006467:Hemophilia A / Q000097:blood* / Q000175:diagnosis; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000097:blood*; D008875:Middle Aged
chemical_list: D017152:Antibodies, Antiphospholipid; D016682:Lupus Coagulation Inhibitor; D005169:Factor VIII